Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 06, 2018 07:57 ET | Source: Vida Strategic Partners, Inc.

Vida Strategic Partners President and CEO to Participate on Investor Relations Best Practices Panel at NIRI 2018

SAN FRANCISCO, June 06, 2018 (GLOBE NEWSWIRE) -- Vida Strategic Partners, an advisory firm supporting the financial, operational and communications goals of life science and healthcare companies,...
March 05, 2015 11:00 ET | Source: Rock For Life

San Francisco Suicide Prevention Partners With Punk Rockers to Save Lives

SAN FRANCISCO, CA--(Marketwired - Mar 5, 2015) - San Francisco Suicide Prevention (SFSP) announced today that they will once again partner with Global Affront, a San Francisco punk rock band, to...
January 12, 2015 07:35 ET | Source: Global Blood Therapeutics

Global Blood Therapeutics Announces First Cohort Dosed in Phase I/II Trial of GBT440 in Sickle Cell Disease

SOUTH SAN FRANCISCO, CA--(Marketwired - Jan 12, 2015) - Global Blood Therapeutics (GBT), a biopharmaceutical company developing novel, small molecule therapeutics for the treatment of severe blood...
January 08, 2015 07:35 ET | Source: Global Blood Therapeutics

Willie L. Brown, Jr. Joins the Board of Directors of Global Blood Therapeutics

SOUTH SAN FRANCISCO, CA--(Marketwired - Jan 8, 2015) - Global Blood Therapeutics (GBT), a biopharmaceutical company developing novel, small molecule therapeutics for the treatment of severe blood...
January 06, 2015 07:35 ET | Source: Global Blood Therapeutics

Global Blood Therapeutics Completes $48 Million Series B Financing

SOUTH SAN FRANCISCO, CA--(Marketwired - Jan 6, 2015) - Global Blood Therapeutics (GBT), a biopharmaceutical company developing novel, small molecule therapeutics for the treatment of severe blood...
January 05, 2015 07:35 ET | Source: Global Blood Therapeutics

Global Blood Therapeutics to Present at Upcoming Investor Conferences

SOUTH SAN FRANCISCO, CA--(Marketwired - Jan 5, 2015) - Global Blood Therapeutics (GBT), a biopharmaceutical company developing novel small molecule therapeutics for the treatment of severe blood...
December 08, 2014 10:00 ET | Source: Global Blood Therapeutics

Global Blood Therapeutics' GBT440 Demonstrates Ability to Positively Impact Fundamental Sickle Cell Disease (SCD) Processes in Studies Presented at 2014 American Society of Hematology (ASH) Conference

SOUTH SAN FRANCISCO, CA--(Marketwired - Dec 8, 2014) - Global Blood Therapeutics (GBT), a biopharmaceutical company developing novel, orally available therapeutics for the treatment of severe...
December 02, 2014 07:35 ET | Source: Global Blood Therapeutics

Global Blood Therapeutics to Present New Data Highlighting Therapeutic Potential of GBT440 in Sickle Cell Disease (SCD) at 2014 American Society of Hematology (ASH) Conference

SOUTH SAN FRANCISCO, CA--(Marketwired - Dec 2, 2014) - Global Blood Therapeutics (GBT), a biopharmaceutical company developing novel, orally available therapeutics for the treatment of severe...